|
End-of-day quote
Shenzhen S.E.
2026-11-17
|
5-day change | 1st Jan Change | ||
| 2.840 CNY | -1.39% |
|
-5.96% | -7.49% |
| Market Cap | 6.33B 950M 863M 797M 720M 1.36B 89.19B 1.41B 9.59B 3.8B 47.86B 3.56B 3.49B 152B | P/E 2024 |
24.2x | P/E 2025 | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 5.49B 824M 749M 692M 625M 1.18B 77.39B 1.22B 8.32B 3.3B 41.53B 3.09B 3.03B 132B | EV / Sales 2024 |
2.12x | EV / Sales 2025 | 2.82x |
| Free-Float |
90.2% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.39% | ||
| 1 week | -5.96% | ||
| Current month | -2.07% | ||
| 1 month | -19.55% | ||
| 3 months | -37.31% | ||
| 6 months | -9.84% | ||
| Current year | -7.49% |
| 1 week | 2.81 | 3.1 | |
| 1 month | 2.8 | 3.45 | |
| Current year | 2.37 | 5.1 | |
| 1 year | 2.37 | 5.1 | |
| 3 years | 1.66 | 5.1 | |
| 5 years | 1.66 | 5.1 | |
| 10 years | 1.66 | 9.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Feng Guo
CEO | Chief Executive Officer | 53 | 2022-12-25 |
Kang Zhou
PRN | Corporate Officer/Principal | 42 | 2018-04-17 |
Yue Yin Liu
PRN | Corporate Officer/Principal | 40 | 2019-05-22 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Yin Liu
BRD | Director/Board Member | 40 | 2025-03-13 |
Lei Feng Guo
BRD | Director/Board Member | 53 | 2022-11-10 |
Kang Zhou
BRD | Director/Board Member | 42 | 2022-11-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/2/25 | Sell | 587,500 | 0.0283% | |||
| 7/2/25 | Sell | Director | 259,600 | 0.0125% | ||
| 7/2/25 | Sell | 587,500 | 0.0283% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.39% | -5.96% | -17.92% | +11.37% | 963M | ||
| -1.17% | -1.14% | +38.59% | +139.29% | 1,275B | ||
| -1.14% | -0.32% | +40.23% | +86.85% | 680B | ||
| -0.72% | -0.40% | +25.10% | +111.66% | 521B | ||
| -0.95% | +0.90% | +41.16% | +70.62% | 389B | ||
| -0.92% | -3.10% | +54.49% | +40.99% | 356B | ||
| -1.80% | -0.86% | +26.04% | +58.53% | 305B | ||
| -1.90% | -0.85% | +1.28% | +34.17% | 287B | ||
| -1.43% | -1.90% | +33.56% | +71.97% | 250B | ||
| +1.00% | -0.79% | +36.61% | +124.67% | 208B | ||
| Average | -1.08% | -0.29% | +27.91% | +75.01% | 427B | |
| Weighted average by Cap. | -1.05% | +0.76% | +34.96% | +95.61% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.44B 366M 333M 307M 278M 524M 34.38B 542M 3.7B 1.46B 18.45B 1.37B 1.34B 58.43B | 2.14B 320M 291M 269M 243M 458M 30.08B 474M 3.23B 1.28B 16.14B 1.2B 1.18B 51.12B |
| Net income | 233M 34.91M 31.72M 29.31M 26.47M 49.96M 3.28B 51.71M 352M 140M 1.76B 131M 128M 5.57B | 377M 56.53M 51.36M 47.46M 42.86M 80.89M 5.31B 83.74M 571M 226M 2.85B 212M 208M 9.02B |
| Net Debt | -509M -76.3M -69.32M -64.05M -57.85M -109M -7.16B -113M -770M -305M -3.84B -286M -280M -12.18B | -838M -126M -114M -106M -95.31M -180M -11.8B -186M -1.27B -503M -6.33B -472M -462M -20.06B |
Employees
2,350
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-16 | CN¥2.840 | -1.39% | 86,104,320 |
| 26-11-16 | CN¥2.880 | -1.71% | 91,021,084 |
| 26-11-13 | CN¥2.930 | -3.62% | 140,547,205 |
| 26-11-12 | CN¥3.040 | -0.98% | 134,716,235 |
| 26-11-11 | CN¥3.070 | +0.33% | 113,169,172 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002437 Stock
Select your edition
All financial news and data tailored to specific country editions
















